Given the systemic effects of PI3Kγ and PD-L1 inhibition during experimental HNSCC, we next determined the impact of this novel combination on myelopoiesis and terminal differentiation of specific myeloid subsets crucial for immunity against HNSCC within the bone marrow. This evidence concerns the gene CD274 and head and neck squamous cell carcinoma.